Free Biopharma Stock Content

$XBI $130.62 +0.28% Covid Updates $GILD -0.5% Veklury® (Remdesivir) Significantly Reduced Risk of Hospitalization in High-Risk Patients...

Summary: Biomedical conferences throughout the year include company presentations that may report significant clinical trial updates...

$XBI $130.25 +1.16% Pipeline Updates $BLUE +0.1% bluebird bio Submits Biologics License Application (BLA) to FDA for betibeglogene...

$XBI $128.76 -3.10% Covid Updates $EIGR -2.5% Eiger BioPharmaceuticals Announces Interim Analysis and Continuation of Dosing of...

$XBI $133 +1% Covid Updates $PFE -1% FDA ADVISORY COMMITTEE VOTES UNANIMOUSLY IN FAVOR OF COMIRNATY® BOOSTER FOR EMERGENCY USE IN PEOPLE...

$XBI $131.00 +0.40% Covid Updates $ABCL +5.3% Emergency Use Authorization of AbCellera-Discovered Bamlanivimab Administered with...

$XBI $130.43 +1.0% Pipeline Updates $BTAI -0.1%BioXcel Therapeutics Presents Results from Ongoing Phase 2 Trial of BXCL701 in Combination...

$XBI $128.99 -1.59% Covid Updates $RDHL -32.7% RedHill Biopharma Reports Top-Line Data from Opaganib Phase 2/3 Study in Severe COVID-19...

$XBI $131.08 -0.50% Covid Updates $TNXP -0.80% Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA for TNX-1800 as a...

$XBI $132 -2% Covid Updates $NVAX Novavax Statement on Takeda Agreement to Provide 150 Million Doses of NVX-CoV2373 to the Government of...

(Originally published on 9/10/2021; last updated on 12/7/2021) Summary: IPOs occur when private companies go public (offer shares to the...

$XBI $132.82 +0.39% Covid Updates $HGEN -47.3% FDA has declined Humanigen’s Emergency Use Authorization (EUA) Request for Lenzilumab in...

$XBI $132.31 -0.87% Covid Updates $NVAX -1.4% Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and...

$XBI $133.47 -0.70% Covid Updates $BNTX $PFE +3.7% Submit a Variation to EMA with the Data in Support of a Booster Dose of COMIRNATY®....

$XBI $134 -2% Covid Updates $CYDY +3% CytoDyn to Hold Webcast on September 8 to Discuss Results from mTNBC Trials, HIV BLA Status, and...

(Last updated 9/14/2021.) For our most comprehensive and up-to-date ESMO21 investor info, click HERE for our BPIQ ESMO21 Investor Hub...

$XBI $136.53 +1.07% Covid Updates $SRNE +0.1% Sorrento Announces Enrollment of First Subject in Brazil Phase 2 Study of COVI-MSC for...

$XBI $135.08 +1.70% Covid Updates $RIGL +8.2% Data from NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19...

$XBI $132.84 +0.92% Pipeline Updates $EGRX +10.2% Eagle Pharmaceuticals Wins Vasopressin Patent Trial. source $PSTX -19.3% Poseida...

$XBI $131.63 -0.30% Covid Updates $NVAX +2.9% Novavax Statement on CDC Guidance Update for COVID-19 Clinical Trial Participants source...